Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...
Kenvue, the maker of Tylenol, is pushing back against proposed safety label changes linking its use during pregnancy to autism or ADHD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback